Free Trial
NASDAQ:GOVX

GeoVax Labs (GOVX) Stock Price, News & Analysis

GeoVax Labs logo
$0.72 +0.00 (+0.61%)
As of 08/1/2025 04:00 PM Eastern

About GeoVax Labs Stock (NASDAQ:GOVX)

Key Stats

Today's Range
$0.69
$0.74
50-Day Range
$0.48
$1.32
52-Week Range
$0.43
$11.18
Volume
533,532 shs
Average Volume
2.02 million shs
Market Capitalization
$11.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.88
Consensus Rating
Buy

Company Overview

GeoVax Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

GOVX MarketRank™: 

GeoVax Labs scored higher than 49% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GeoVax Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    GeoVax Labs has only been the subject of 1 research reports in the past 90 days.

  • Read more about GeoVax Labs' stock forecast and price target.
  • Earnings Growth

    Earnings for GeoVax Labs are expected to grow in the coming year, from ($4.49) to ($1.12) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GeoVax Labs is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GeoVax Labs is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    GeoVax Labs has a P/B Ratio of 4.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    15.51% of the outstanding shares of GeoVax Labs have been sold short.
  • Short Interest Ratio / Days to Cover

    GeoVax Labs has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GeoVax Labs has recently decreased by 17.94%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    GeoVax Labs does not currently pay a dividend.

  • Dividend Growth

    GeoVax Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.51% of the outstanding shares of GeoVax Labs have been sold short.
  • Short Interest Ratio / Days to Cover

    GeoVax Labs has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GeoVax Labs has recently decreased by 17.94%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    GeoVax Labs has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 12 news articles for GeoVax Labs this week, compared to 2 articles on an average week.
  • Search Interest

    26 people have searched for GOVX on MarketBeat in the last 30 days. This is an increase of 8% compared to the previous 30 days.
  • MarketBeat Follows

    Only 7 people have added GeoVax Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -46% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GeoVax Labs insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.20% of the stock of GeoVax Labs is held by insiders.

  • Percentage Held by Institutions

    Only 6.09% of the stock of GeoVax Labs is held by institutions.

  • Read more about GeoVax Labs' insider trading history.
Receive GOVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GeoVax Labs and its competitors with MarketBeat's FREE daily newsletter.

GOVX Stock News Headlines

What is Roth Capital's Forecast for GeoVax Labs Q3 Earnings?
FY2028 EPS Estimates for GeoVax Labs Reduced by Roth Capital
Alien rocks potentially worth trillions…
It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 trillion. These rare elements can’t be found on land… only in one high-pressure zone so extreme it could crush a human instantly. Inside? Materials essential to AI, quantum computing, and advanced weapons tech. That’s why global superpowers are in a race to secure them—and why Trump just signed an Executive Order pushing for immediate extraction.
See More Headlines

GOVX Stock Analysis - Frequently Asked Questions

GeoVax Labs' stock was trading at $2.47 at the beginning of 2025. Since then, GOVX shares have decreased by 70.7% and is now trading at $0.7247.

GeoVax Labs Inc. (NASDAQ:GOVX) posted its quarterly earnings results on Monday, July, 28th. The company reported ($0.35) EPS for the quarter, topping analysts' consensus estimates of ($0.41) by $0.06. The company earned $0.85 million during the quarter, compared to analyst estimates of $0.37 million. GeoVax Labs had a negative net margin of 403.88% and a negative trailing twelve-month return on equity of 408.80%.
Read the conference call transcript
.

GeoVax Labs's stock reverse split on the morning of Wednesday, January 31st 2024.The 1-15 reverse split was announced on Wednesday, January 31st 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 31st 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of GOVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GeoVax Labs investors own include Plug Power (PLUG), FuelCell Energy (FCEL), Workhorse Group (WKHS), KALA BIO (KALA), Lipocine (LPCN), Fortress Biotech (FBIO) and Ovid Therapeutics (OVID).

Company Calendar

Last Earnings
7/28/2025
Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GOVX
CIK
832489
Employees
10
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$8.00
Potential Upside/Downside
+1,124.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.99 million
Net Margins
-403.88%
Pretax Margin
-403.88%
Return on Equity
-408.80%
Return on Assets
-279.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.03
Quick Ratio
3.62

Sales & Book Value

Annual Sales
$3.95 million
Price / Sales
2.92
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.18 per share
Price / Book
4.03

Miscellaneous

Outstanding Shares
15,930,000
Free Float
15,734,000
Market Cap
$11.54 million
Optionable
Not Optionable
Beta
3.27

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:GOVX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners